HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of the vitamin D receptor gene start codon Fok I polymorphism with calcium oxalate stone disease.

AbstractOBJECTIVE:
To assess the use of Fok I polymorphism (the most frequent polymorphism, at the start codon of the vitamin D receptor gene, VDR) as a convenient genetic marker in identifying the cause of urolithiasis.
PATIENTS, SUBJECTS AND METHODS:
A normal control group of 90 healthy subjects and 146 patients with calcium oxalate stones were examined. Using polymerase chain reaction (PCR)-based restriction analysis, the relationship between Fok I polymorphism and urolithiasis was evaluated. An unexcisable length of 265 bp was identified (allele CC) and two fragments (169 bp and 96 bp) identified as excisable lengths (allele TT).
RESULTS:
There was a statistically significant difference between the groups (chi-square test, P < 0.05) for the genotype of the VDR Fok I start codon polymorphism. The odds ratio (95% confidence interval) for the C allele in those at risk of stone disease was 1.672 (1.149-2.432).
CONCLUSIONS:
These results suggest that the VDR Fok I start codon polymorphism may be a good candidate for a genetic marker in calcium oxalate stone disease.
AuthorsW C Chen, H Y Chen, H F Lu, C D Hsu, F J Tsai
JournalBJU international (BJU Int) Vol. 87 Issue 3 Pg. 168-71 (Feb 2001) ISSN: 1464-4096 [Print] England
PMID11167636 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Codon
  • Receptors, Calcitriol
  • Calcium Oxalate
Topics
  • Adult
  • Aged
  • Calcium Oxalate
  • Codon (genetics)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction (methods)
  • Polymorphism, Genetic
  • Receptors, Calcitriol (genetics)
  • Risk Factors
  • Urinary Calculi (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: